"Radionuclide therapy: radiobiological basis and clinical implications"
November 12th, 2026
12:00 PM – 1:00 PM EST (lunch is provided)
"Radionuclide therapy: radiobiological basis and clinical implications"
November 12th, 2026
12:00 PM – 1:00 PM EST (lunch is provided)
forms.gle/NsL9rxMCAZwv...
forms.gle/NsL9rxMCAZwv...
Authors provide a conceptual overview of RLC & major translational barrier
jnm.snmjournals.org/content/67/1...
Authors provide a conceptual overview of RLC & major translational barrier
jnm.snmjournals.org/content/67/1...
The last time we did this, I got the Fist Bump of Safety.
The last time we did this, I got the Fist Bump of Safety.
The session explored new expanded radionuclide portfolio and path towards clinical applications, highlighting regulations, technical requirements, dosimetry and alignment with EANM and PRAC.
🔗 prismap-plus.eu
The session explored new expanded radionuclide portfolio and path towards clinical applications, highlighting regulations, technical requirements, dosimetry and alignment with EANM and PRAC.
🔗 prismap-plus.eu
Sometimes the patient can’t get through the scan. Here’s an incomplete whole body radionuclide bone scan. Go in feet first & then the table backs you out as the rectangular detector acquires the data. They were pretty much out in the clear by the time this much was imaged, but
Sometimes the patient can’t get through the scan. Here’s an incomplete whole body radionuclide bone scan. Go in feet first & then the table backs you out as the rectangular detector acquires the data. They were pretty much out in the clear by the time this much was imaged, but
This is based on decades of failures to manage selenium mine drainage, coal flyash leachate, mercury emissions, drinking water contamination, sewage, ethylene oxide analyses, PFOA, & microcystins.
This is based on decades of failures to manage selenium mine drainage, coal flyash leachate, mercury emissions, drinking water contamination, sewage, ethylene oxide analyses, PFOA, & microcystins.
Extract: The Lovell lab seeks a Research Associate for a 12-month contract focusing on targeted radionuclide therapy for cancer treatment. Candidates should have a PhD in Chemistry or related fields and expertise in display technologies.
Extract: The Lovell lab seeks a Research Associate for a 12-month contract focusing on targeted radionuclide therapy for cancer treatment. Candidates should have a PhD in Chemistry or related fields and expertise in display technologies.
interestingengineering.com/science/cher...
#NuclearEnergy #Resilience #CriticalInfrastructure
interestingengineering.com/science/cher...
#NuclearEnergy #Resilience #CriticalInfrastructure
#UniversityOfNevadaPress
#UniversityOfNevadaPress
I Von Polenz, F Giammarile & L Mansi recommend to integrate radiotheranostics into national cancer planning to avoid widening cancer survival gaps.
www.thelancet.com/journals/lan...
I Von Polenz, F Giammarile & L Mansi recommend to integrate radiotheranostics into national cancer planning to avoid widening cancer survival gaps.
www.thelancet.com/journals/lan...